Bone Marrow Transplantation News

Researchers have identified the chemical process behind the anticancer properties of piperlongumine, the compound found in the spicy Indian pepper plant.

The European Conference on Infections in Leukemia, or ECIL, recently updated treatment guidelines for fungal infections in patients with leukemia and hematopoietic stem cell transplant recipients. Leaders of the conference now strongly recommend the use of echinocandin as a first-line therapy for invasive candidiasis and isavuconazole as another treatment option for invasive aspergillosis.  

Nearly one in five U.S. cancer survivors take medications for anxiety or depression, according to study results published in the Journal of Clinical Oncology.

Pediatric oncology patients with high degrees of symptom-related suffering appeared more likely than their parents to acknowledge the benefits of early palliative care, according to survey results.

Bruce E. Johnson, MD, FASCO, professor of medicine at Harvard Medical School and institute physician at Dana-Farber Cancer Institute, will become president of ASCO during the society’s annual meeting in June.

The FDA granted fast track designation to MSC-100-IV for the treatment of children with steroid-refractory acute graft-versus-host disease following bone marrow transplantation, according to the drug’s manufacturer.

Exercise and psychological interventions provide greater benefit to patients than pharmaceutical drugs for reducing cancer-related fatigue, according to results of a meta-analysis.

This month’s top news includes a number of key studies in hematology and oncology.

The addition of an in-house specialty pharmacy at a cancer center in Connecticut reduced the amount of time patients waited for oral cancer medications; prevented errors associated with filling, dispensing and taking oral chemotherapy; and improved overall quality of care, according to a study being presented at the Quality Care Symposium.

Several cancer survivorship care models are available to help integrate primary care providers into the long-term follow-up care of cancer survivors.